31. Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPARγ agonist in vitro and in MPTP-treated mice. (27th August 2015) Authors: Lecca, D.; Nevin, D.K.; Mulas, G.; Casu, M.A.; Diana, A.; Rossi, D.; Sacchetti, G.; Carta, A.R. Journal: Neuroscience Issue: Volume 302(2015) Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. NOTCH1 MUTATED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS ARE CHARACTERIZED BY a MYC‐RELATED OVEREXPRESSION OF NUCLEOPHOSMIN‐1 AND RIBOSOME ASSOCIATED COMPONENTS. (June 2017) Authors: Pozzo, F.; Bittolo, T.; Vendramini, E.; Bomben, R.; Bulian, P.; Rossi, F.M.; Zucchetto, A.; Tissino, E.; Degan, M.; D'Arena, G.; Di Raimondo, F.; Zaja, F.; Pozzato, G.; Rossi, D.; Gaidano, G.; Del Poeta, G.; Gattei, V.; Dal Bo, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. OP0212 Very Long-Term Effects of the "4 Plus 2 Infusion Protocol" of Rituximab Alone in Patients with HCV-Associated Mixed Cryoglobulinemia with Diffuse Membranoproliferative Glomerulonephritis, Severe Polyneuropathy and Necrotic Ulcers of Skin. (23rd January 2014) Authors: Roccatello, D.; Sciascia, S.; Baldovino, S.; Rossi, D. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. OP0217 Ultrasound-Detected Synovitis and Tenosynovitis Independently Associate with Flare in Patients with Rheumatoid Arthritis in Clinical Remission. (9th June 2015) Authors: Bellis, E.; Scirè, C.A.; Carrara, G.; Adinolfi, A.; Batticciotto, A.; Bortoluzzi, A.; Cagnotto, G.; Caprioli, M.; Canzoni, M.; Cavatorta, F.P.; De Lucia, O.; Di Sabatino, V.; Draghessi, A.; Filippou, G.; Farina, I.; Focherini, M.C.; Gabba, A.; Gutierrez, M.; Idolazzi, L.; Luccioli, F. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. Optical signature of erythrocytes by light scattering in microfluidic flows1. Issue 16 (21st August 2015) Authors: Dannhauser, D.; Rossi, D.; Causa, F.; Memmolo, P.; Finizio, A.; Wriedt, T.; Hellmers, J.; Eremin, Y.; Ferraro, P.; Netti, P. A. Journal: Lab on a chip Issue: Volume 15:Issue 16(2015) Page Start: 3278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. Our experience about the particular surgical management of total hip replacement in two patients with severe haemophilic arthropathy: case report. (19th April 2013) Authors: Ruosi, C.; Rossi, D.; Coppola, A.; Liccardo, S.; Granata, F.; Barbato, A.; Cimino, E.; Di Minno, M. N. D. Journal: Haemophilia Issue: Volume 19:Number 3(2013:May) Page Start: e184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. P1282: DISEASE-SPECIFIC U1 SPLICEOSOMAL RNA MUTATIONS IN MATURE B-CELL NEOPLASMS. (23rd June 2022) Authors: Nadeu, F.; Shuai, S.; Clot, G.; Hilton, L. K.; Diaz-Navarro, A.; Martín, S.; Royo, R.; Baumann, T.; Kulis, M.; López-Oreja, I.; Cossio, M.; Lu, J.; Ljungström, V.; Young, E.; Plevova, K.; Knisbacher, B. A.; Lin, Z.; Hahn, C. K.; Bousquets, P.; Alcoceba, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. P211 Phase 2 neoadjuvant trial: myocet (M), cyclophosphamide (C) +/− trastuzumab (T) and paclitaxel (P) +/− T. (March 2015) Authors: Pistilli, B.; Benedetti, G.; Rossi, D.; Baldelli, A.M.; Magalotti, C.; Casadei, V.; Foghini, L.; Staffolani, M.; Fiorentini, G.; Latini, L. Journal: Breast Issue: Volume 24(2015)Supplement 1 Page Start: S98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. P646: EFFECTIVENESS AND SAFETY OF VENETOCLAX IN COMBINATION WITH RITUXIMAB (VENR) IN R/R CLL PATIENTS WITH OR WITHOUT RISK-ASSOCIATED GENETIC MARKERS – DATA FROM THE OBSERVATIONAL VERVE STUDY. (23rd June 2022) Authors: Schwaner, I.; Hebart, H.; Losem, C.; Wolff, T.; Famulla, K.; Huelsenbeck, J.; Schmidt, B.; Nösslinger, T.; Rossi, D. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. P647: SAFETY AND EFFECTIVENESS OF VENETOCLAX MONOTHERAPY IN R/R CLL PATIENTS WITH OR WITHOUT RISK-ASSOCIATED GENETIC MARKERS – DATA FROM THE OBSERVATIONAL VERVE STUDY. (23rd June 2022) Authors: Schwaner, I.; Hebart, H.; Losem, C.; Wolff, T.; Famulla, K.; Huelsenbeck, J.; Schmidt, B.; Nösslinger, T.; Rossi, D. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗